Showing 102,281-102,300 of 108,671 items.
| # | Code | Name | Market | |
|---|---|---|---|---|
| 102281 | | MERpF | MERRILL PF CP TST V 7.28%TOPRS | NYSE |
| 102282 | | MERpG | MERRILL LYNCH & CO INC DEP SH REPSTG 1/1200 PFD SER 1 | NYSE |
| 102283 | | MERpH | MERRILL LYNCH & CO., INC.DEP SHR RPTNG 1/1200TH PFD SER 2 | NYSE |
| 102284 | | MERpI | MERRILL LYNCH & CO.,INC DEP SHR RPSNTG 1/1200 PFD SER 3 | NYSE |
| 102285 | | MERpJ | MERRILL LYNCH & CO.,INC DEP SHR RPSNTG 1/1200 PFD SER 4 | NYSE |
| 102286 | | MERpL | Merrill Lynch Dep Sh Repstg 1/1200th Pfd Ser 5 | NYSE |
| 102287 | | MERpM | MERRILL LYNCH CAP TRII GUARANTEED TRUST PFD SECS 6.450% | NYSE |
| 102288 | | MERpN | MERRILL LYNCH & CO INC 6.7% PRF PERP SER 6 | NYSE |
| 102289 | | MERpO | MERRILL LYNCH & CO INC 6.25% PRF PERP SER 7 | NYSE |
| 102290 | | MERpP | Merrill Lynch Capital Trust Iii | NYSE |
| 102291 | | MERpP.CL | Merrill Lynch Capital Trust Iii | NYSE |
| 102292 | | MERpQ | MERRILL LYNCH & CO INC DEP SHS REPSTG 1/1200TH PFD | NYSE |
| 102293 | | MDNA | Medicenna Therapeutics Corp. Common Shares | NASDAQ |
| 102294 | | MERw | MERRILL, LYNCH & CO INC (W.I.) | NYSE |
| 102295 | | MESG | XURA INC COM (DE) | NASDAQ |
| 102296 | | TRAQ.WS | Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share | NYSE |
| 102297 | | FNGD | MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038 | NYSE |
| 102298 | | MFApA | MFA FINANCIAL, INC 8.5% CUM REDEM PFD SER A | NYSE |
| 102299 | | MFBC | MFB CORP | OTC |
| 102300 | | PGGCY | PIAGGIO & C SPA UNSP/ADR | OTC |